Copyright
©The Author(s) 2025.
World J Stem Cells. Jun 26, 2025; 17(6): 107833
Published online Jun 26, 2025. doi: 10.4252/wjsc.v17.i6.107833
Published online Jun 26, 2025. doi: 10.4252/wjsc.v17.i6.107833
Table 2 Transplantation of mesenchymal stem cells in peripheral nerve injuries
Cell | Delivery | Models | Cell numbers | Outcome | Notes | Ref. |
AT-MSCs (canine) | Perineural | Rat sciatic nerve crush | 1 × 106 | Improved electrophysiological and motor recovery | Assessment performed for 4 weeks | [83] |
AT-MSCs (rat) | Intraperitoneal | Rat sciatic nerve transection and suture repair | 2 × 106 | Improvement in nerve regeneration and functionality | No difference was observed in compound muscle action potential latency between the saline and MSC groups | [81] |
BM-MSCs (rat) | IM and IV | Small gap neurorrhaphy (rat sciatic nerve) | 1 × 106 | Improvements in the sciatic function index, nerve conduction velocity, and myelin sheath thickness | The IM group showed better results compared with the IV group | [80] |
BM-MSCs (rat) | IV and epineural | Rat sciatic nerve transection and suture repair | IV: 1 × 106. Epineural: 5 × 104 | Enhancement in the recovery rate of compound muscle action potential amplitudes and axon counts | IV administration showed a more pronounced effect on electromotor recovery, while epineural injection was more effective in increasing fiber counts | [82] |
BM-MSCs (rat) | Local injection and IV | Rat sciatic nerve transection/repair and individual nerve transection/repair | 5 × 106 | Improvements in motor function recovery in both models | The motor function recovery was significantly more pronounced in the individual nerve transection/repair model compared with the sciatic nerve transection/repair model | [85] |
BM-MSCs (rat) | Subepineural | Rat sciatic nerve transection and surgical coaptation | 5 × 105 | Improvements in the sciatic function index | The group treated with MSCs and immunomodulators had better functional recovery than the group treated with MSCs alone. Immunomodulation using LPS and FK506 can improve MSC survival after transplantation | [84] |
- Citation: Ferreira LVO, Roballo KCS, Amorim RM. Mesenchymal stem cell-based therapy for peripheral nerve injuries: A promise or reality? World J Stem Cells 2025; 17(6): 107833
- URL: https://www.wjgnet.com/1948-0210/full/v17/i6/107833.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i6.107833